Found 47 hits of ki for UniProtKB: P12872 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Promotilin
(Homo sapiens (Human)) | BDBM50143037
(CHEMBL411576 | MOTILIN)Show SMILES CCC(C)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(N)Cc1ccccc1)C(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(C(C)O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCSC)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(O)=O)C(=O)NC(CCCCN)C(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC(N)=O)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCC(N)=O)C(O)=O Show InChI InChI=1S/C120H188N34O35S/c1-9-64(6)97(152-114(184)86-31-22-53-154(86)117(187)96(63(4)5)151-99(169)70(123)56-66-23-12-10-13-24-66)115(185)150-84(57-67-25-14-11-15-26-67)113(183)153-98(65(7)155)116(186)149-83(58-68-32-34-69(156)35-33-68)101(171)135-60-91(161)136-75(39-45-93(163)164)105(175)147-82(55-62(2)3)111(181)145-77(37-43-88(125)158)106(176)140-73(29-20-51-132-119(128)129)103(173)146-80(48-54-190-8)110(180)142-76(36-42-87(124)157)107(177)144-79(41-47-95(167)168)108(178)139-72(28-17-19-50-122)102(172)143-78(40-46-94(165)166)109(179)141-74(30-21-52-133-120(130)131)104(174)148-85(59-90(127)160)112(182)138-71(27-16-18-49-121)100(170)134-61-92(162)137-81(118(188)189)38-44-89(126)159/h10-15,23-26,32-35,62-65,70-86,96-98,155-156H,9,16-22,27-31,36-61,121-123H2,1-8H3,(H2,124,157)(H2,125,158)(H2,126,159)(H2,127,160)(H,134,170)(H,135,171)(H,136,161)(H,137,162)(H,138,182)(H,139,178)(H,140,176)(H,141,179)(H,142,180)(H,143,172)(H,144,177)(H,145,181)(H,146,173)(H,147,175)(H,148,174)(H,149,186)(H,150,185)(H,151,169)(H,152,184)(H,153,183)(H,163,164)(H,165,166)(H,167,168)(H,188,189)(H4,128,129,132)(H4,130,131,133) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| Purchase
CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.160 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by PDSP Ki Database
| |
Br J Pharmacol 140: 948-54 (2003)
Article DOI: 10.1038/sj.bjp.0705505
BindingDB Entry DOI: 10.7270/Q2N58JZF |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86314
(CAS_0 | NSC_0 | [Nle13]-Motilin)Show SMILES [#6]-[#6]-[#6]-[#6]-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(-[#8])cc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccccc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6@@H](-[#6])-[#6]-[#6])-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r| Show InChI InChI=1S/C122H192N34O35/c1-9-11-14-30-74(104(174)145-79(40-46-89(126)159)110(180)147-82(45-51-97(169)170)111(181)142-75(32-20-22-53-124)105(175)146-81(44-50-96(167)168)112(182)144-77(34-24-55-135-122(132)133)107(177)150-87(61-92(129)162)114(184)140-73(31-19-21-52-123)102(172)136-63-94(164)139-83(120(190)191)42-48-91(128)161)141-106(176)76(33-23-54-134-121(130)131)143-109(179)80(41-47-90(127)160)148-113(183)84(57-64(3)4)149-108(178)78(43-49-95(165)166)138-93(163)62-137-103(173)85(60-70-36-38-71(158)39-37-70)151-118(188)100(67(8)157)155-115(185)86(59-69-28-17-13-18-29-69)152-117(187)99(66(7)10-2)154-116(186)88-35-25-56-156(88)119(189)98(65(5)6)153-101(171)72(125)58-68-26-15-12-16-27-68/h12-13,15-18,26-29,36-39,64-67,72-88,98-100,157-158H,9-11,14,19-25,30-35,40-63,123-125H2,1-8H3,(H2,126,159)(H2,127,160)(H2,128,161)(H2,129,162)(H,136,172)(H,137,173)(H,138,163)(H,139,164)(H,140,184)(H,141,176)(H,142,181)(H,143,179)(H,144,182)(H,145,174)(H,146,175)(H,147,180)(H,148,183)(H,149,178)(H,150,177)(H,151,188)(H,152,187)(H,153,171)(H,154,186)(H,155,185)(H,165,166)(H,167,168)(H,169,170)(H,190,191)(H4,130,131,134)(H4,132,133,135)/t66-,67+,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,98-,99-,100-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.447 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by PDSP Ki Database
| |
Br J Pharmacol 140: 948-54 (2003)
Article DOI: 10.1038/sj.bjp.0705505
BindingDB Entry DOI: 10.7270/Q2N58JZF |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85994
([leu13]pMOT(1-19))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C108H168N30O30/c1-10-58(8)87(136-103(165)78-29-21-47-138(78)106(168)86(57(6)7)135-90(152)64(110)50-60-22-13-11-14-23-60)104(166)134-77(51-61-24-15-12-16-25-61)102(164)137-88(59(9)139)105(167)133-76(52-62-30-32-63(140)33-31-62)91(153)121-54-82(144)122-68(36-41-83(145)146)95(157)132-75(49-56(4)5)101(163)128-69(34-39-79(111)141)96(158)125-67(28-20-46-120-108(117)118)94(156)131-74(48-55(2)3)100(162)129-70(35-40-80(112)142)97(159)127-72(38-43-85(149)150)98(160)123-65(26-17-18-44-109)92(154)126-71(37-42-84(147)148)99(161)124-66(27-19-45-119-107(115)116)93(155)130-73(89(114)151)53-81(113)143/h11-16,22-25,30-33,55-59,64-78,86-88,139-140H,10,17-21,26-29,34-54,109-110H2,1-9H3,(H2,111,141)(H2,112,142)(H2,113,143)(H2,114,151)(H,121,153)(H,122,144)(H,123,160)(H,124,161)(H,125,158)(H,126,154)(H,127,159)(H,128,163)(H,129,162)(H,130,155)(H,131,156)(H,132,157)(H,133,167)(H,134,166)(H,135,152)(H,136,165)(H,137,164)(H,145,146)(H,147,148)(H,149,150)(H4,115,116,119)(H4,117,118,120)/t58-,59+,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,86-,87-,88-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.980 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85614
([Leu13]motilin | [leu13]pMOT(1-22))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r| Show InChI InChI=1S/C121H190N34O35/c1-10-65(8)98(153-115(185)87-32-23-53-155(87)118(188)97(64(6)7)152-100(170)71(124)56-67-24-13-11-14-25-67)116(186)151-85(57-68-26-15-12-16-27-68)114(184)154-99(66(9)156)117(187)150-84(58-69-33-35-70(157)36-34-69)102(172)136-60-92(162)137-76(40-46-94(164)165)106(176)148-83(55-63(4)5)112(182)145-77(37-43-88(125)158)107(177)141-74(30-21-51-133-120(129)130)104(174)147-82(54-62(2)3)111(181)146-78(38-44-89(126)159)108(178)144-80(42-48-96(168)169)109(179)140-73(29-18-20-50-123)103(173)143-79(41-47-95(166)167)110(180)142-75(31-22-52-134-121(131)132)105(175)149-86(59-91(128)161)113(183)139-72(28-17-19-49-122)101(171)135-61-93(163)138-81(119(189)190)39-45-90(127)160/h11-16,24-27,33-36,62-66,71-87,97-99,156-157H,10,17-23,28-32,37-61,122-124H2,1-9H3,(H2,125,158)(H2,126,159)(H2,127,160)(H2,128,161)(H,135,171)(H,136,172)(H,137,162)(H,138,163)(H,139,183)(H,140,179)(H,141,177)(H,142,180)(H,143,173)(H,144,178)(H,145,182)(H,146,181)(H,147,174)(H,148,176)(H,149,175)(H,150,187)(H,151,186)(H,152,170)(H,153,185)(H,154,184)(H,164,165)(H,166,167)(H,168,169)(H,189,190)(H4,129,130,133)(H4,131,132,134)/t65-,66+,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,97-,98-,99-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM50143037
(CHEMBL411576 | MOTILIN)Show SMILES CCC(C)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(N)Cc1ccccc1)C(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(C(C)O)C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCSC)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(O)=O)C(=O)NC(CCCCN)C(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC(N)=O)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCC(N)=O)C(O)=O Show InChI InChI=1S/C120H188N34O35S/c1-9-64(6)97(152-114(184)86-31-22-53-154(86)117(187)96(63(4)5)151-99(169)70(123)56-66-23-12-10-13-24-66)115(185)150-84(57-67-25-14-11-15-26-67)113(183)153-98(65(7)155)116(186)149-83(58-68-32-34-69(156)35-33-68)101(171)135-60-91(161)136-75(39-45-93(163)164)105(175)147-82(55-62(2)3)111(181)145-77(37-43-88(125)158)106(176)140-73(29-20-51-132-119(128)129)103(173)146-80(48-54-190-8)110(180)142-76(36-42-87(124)157)107(177)144-79(41-47-95(167)168)108(178)139-72(28-17-19-50-122)102(172)143-78(40-46-94(165)166)109(179)141-74(30-21-52-133-120(130)131)104(174)148-85(59-90(127)160)112(182)138-71(27-16-18-49-121)100(170)134-61-92(162)137-81(118(188)189)38-44-89(126)159/h10-15,23-26,32-35,62-65,70-86,96-98,155-156H,9,16-22,27-31,36-61,121-123H2,1-8H3,(H2,124,157)(H2,125,158)(H2,126,159)(H2,127,160)(H,134,170)(H,135,171)(H,136,161)(H,137,162)(H,138,182)(H,139,178)(H,140,176)(H,141,179)(H,142,180)(H,143,172)(H,144,177)(H,145,181)(H,146,173)(H,147,175)(H,148,174)(H,149,186)(H,150,185)(H,151,169)(H,152,184)(H,153,183)(H,163,164)(H,165,166)(H,167,168)(H,188,189)(H4,128,129,132)(H4,130,131,133) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.29 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by PDSP Ki Database
| |
Br J Pharmacol 140: 948-54 (2003)
Article DOI: 10.1038/sj.bjp.0705505
BindingDB Entry DOI: 10.7270/Q2N58JZF |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85979
([ala3,leu13]pMOT(1-14))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C79H120N20O20/c1-10-44(8)65(97-62(105)40-88-76(117)64(43(6)7)98-68(109)50(80)36-46-18-13-11-14-19-46)77(118)96-58(37-47-20-15-12-16-21-47)75(116)99-66(45(9)100)78(119)95-57(38-48-23-25-49(101)26-24-48)69(110)87-39-61(104)89-53(29-32-63(106)107)71(112)94-56(35-42(4)5)74(115)92-54(28-31-60(82)103)72(113)91-52(22-17-33-86-79(84)85)70(111)93-55(34-41(2)3)73(114)90-51(67(83)108)27-30-59(81)102/h11-16,18-21,23-26,41-45,50-58,64-66,100-101H,10,17,22,27-40,80H2,1-9H3,(H2,81,102)(H2,82,103)(H2,83,108)(H,87,110)(H,88,117)(H,89,104)(H,90,114)(H,91,113)(H,92,115)(H,93,111)(H,94,112)(H,95,119)(H,96,118)(H,97,105)(H,98,109)(H,99,116)(H,106,107)(H4,84,85,86)/t44-,45+,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-,65-,66-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86314
(CAS_0 | NSC_0 | [Nle13]-Motilin)Show SMILES [#6]-[#6]-[#6]-[#6]-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(-[#8])cc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccccc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6@@H](-[#6])-[#6]-[#6])-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r| Show InChI InChI=1S/C122H192N34O35/c1-9-11-14-30-74(104(174)145-79(40-46-89(126)159)110(180)147-82(45-51-97(169)170)111(181)142-75(32-20-22-53-124)105(175)146-81(44-50-96(167)168)112(182)144-77(34-24-55-135-122(132)133)107(177)150-87(61-92(129)162)114(184)140-73(31-19-21-52-123)102(172)136-63-94(164)139-83(120(190)191)42-48-91(128)161)141-106(176)76(33-23-54-134-121(130)131)143-109(179)80(41-47-90(127)160)148-113(183)84(57-64(3)4)149-108(178)78(43-49-95(165)166)138-93(163)62-137-103(173)85(60-70-36-38-71(158)39-37-70)151-118(188)100(67(8)157)155-115(185)86(59-69-28-17-13-18-29-69)152-117(187)99(66(7)10-2)154-116(186)88-35-25-56-156(88)119(189)98(65(5)6)153-101(171)72(125)58-68-26-15-12-16-27-68/h12-13,15-18,26-29,36-39,64-67,72-88,98-100,157-158H,9-11,14,19-25,30-35,40-63,123-125H2,1-8H3,(H2,126,159)(H2,127,160)(H2,128,161)(H2,129,162)(H,136,172)(H,137,173)(H,138,163)(H,139,164)(H,140,184)(H,141,176)(H,142,181)(H,143,179)(H,144,182)(H,145,174)(H,146,175)(H,147,180)(H,148,183)(H,149,178)(H,150,177)(H,151,188)(H,152,187)(H,153,171)(H,154,186)(H,155,185)(H,165,166)(H,167,168)(H,169,170)(H,190,191)(H4,130,131,134)(H4,132,133,135)/t66-,67+,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,98-,99-,100-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.95 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by PDSP Ki Database
| |
Br J Pharmacol 140: 948-54 (2003)
Article DOI: 10.1038/sj.bjp.0705505
BindingDB Entry DOI: 10.7270/Q2N58JZF |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85987
([leu13]pMOT(1-16))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C93H143N23O24/c1-10-52(8)76(114-89(137)69-27-20-42-116(69)92(140)75(51(6)7)113-79(127)58(95)45-54-21-13-11-14-22-54)90(138)112-68(46-55-23-15-12-16-24-55)88(136)115-77(53(9)117)91(139)111-67(47-56-28-30-57(118)31-29-56)80(128)102-48-72(121)103-61(34-38-73(122)123)82(130)110-66(44-50(4)5)87(135)107-62(32-36-70(96)119)84(132)105-60(26-19-41-101-93(99)100)81(129)109-65(43-49(2)3)86(134)108-63(33-37-71(97)120)85(133)106-64(35-39-74(124)125)83(131)104-59(78(98)126)25-17-18-40-94/h11-16,21-24,28-31,49-53,58-69,75-77,117-118H,10,17-20,25-27,32-48,94-95H2,1-9H3,(H2,96,119)(H2,97,120)(H2,98,126)(H,102,128)(H,103,121)(H,104,131)(H,105,132)(H,106,133)(H,107,135)(H,108,134)(H,109,129)(H,110,130)(H,111,139)(H,112,138)(H,113,127)(H,114,137)(H,115,136)(H,122,123)(H,124,125)(H4,99,100,101)/t52-,53+,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,75-,76-,77-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85389
(CAS_52906-92-0 | Motilin)Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#16]-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r| Show InChI InChI=1S/C120H188N34O35S/c1-9-64(6)97(152-114(184)86-31-22-53-154(86)117(187)96(63(4)5)151-99(169)70(123)56-66-23-12-10-13-24-66)115(185)150-84(57-67-25-14-11-15-26-67)113(183)153-98(65(7)155)116(186)149-83(58-68-32-34-69(156)35-33-68)101(171)135-60-91(161)136-75(39-45-93(163)164)105(175)147-82(55-62(2)3)111(181)145-77(37-43-88(125)158)106(176)140-73(29-20-51-132-119(128)129)103(173)146-80(48-54-190-8)110(180)142-76(36-42-87(124)157)107(177)144-79(41-47-95(167)168)108(178)139-72(28-17-19-50-122)102(172)143-78(40-46-94(165)166)109(179)141-74(30-21-52-133-120(130)131)104(174)148-85(59-90(127)160)112(182)138-71(27-16-18-49-121)100(170)134-61-92(162)137-81(118(188)189)38-44-89(126)159/h10-15,23-26,32-35,62-65,70-86,96-98,155-156H,9,16-22,27-31,36-61,121-123H2,1-8H3,(H2,124,157)(H2,125,158)(H2,126,159)(H2,127,160)(H,134,170)(H,135,171)(H,136,161)(H,137,162)(H,138,182)(H,139,178)(H,140,176)(H,141,179)(H,142,180)(H,143,172)(H,144,177)(H,145,181)(H,146,173)(H,147,175)(H,148,174)(H,149,186)(H,150,185)(H,151,169)(H,152,184)(H,153,183)(H,163,164)(H,165,166)(H,167,168)(H,188,189)(H4,128,129,132)(H4,130,131,133)/t64-,65+,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,96-,97-,98-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Mayo Clinic in Scottsdale
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 313: 1101-8 (2005)
Article DOI: 10.1124/jpet.104.081562
BindingDB Entry DOI: 10.7270/Q28K77N1 |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85389
(CAS_52906-92-0 | Motilin)Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#16]-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r| Show InChI InChI=1S/C120H188N34O35S/c1-9-64(6)97(152-114(184)86-31-22-53-154(86)117(187)96(63(4)5)151-99(169)70(123)56-66-23-12-10-13-24-66)115(185)150-84(57-67-25-14-11-15-26-67)113(183)153-98(65(7)155)116(186)149-83(58-68-32-34-69(156)35-33-68)101(171)135-60-91(161)136-75(39-45-93(163)164)105(175)147-82(55-62(2)3)111(181)145-77(37-43-88(125)158)106(176)140-73(29-20-51-132-119(128)129)103(173)146-80(48-54-190-8)110(180)142-76(36-42-87(124)157)107(177)144-79(41-47-95(167)168)108(178)139-72(28-17-19-50-122)102(172)143-78(40-46-94(165)166)109(179)141-74(30-21-52-133-120(130)131)104(174)148-85(59-90(127)160)112(182)138-71(27-16-18-49-121)100(170)134-61-92(162)137-81(118(188)189)38-44-89(126)159/h10-15,23-26,32-35,62-65,70-86,96-98,155-156H,9,16-22,27-31,36-61,121-123H2,1-8H3,(H2,124,157)(H2,125,158)(H2,126,159)(H2,127,160)(H,134,170)(H,135,171)(H,136,161)(H,137,162)(H,138,182)(H,139,178)(H,140,176)(H,141,179)(H,142,180)(H,143,172)(H,144,177)(H,145,181)(H,146,173)(H,147,175)(H,148,174)(H,149,186)(H,150,185)(H,151,169)(H,152,184)(H,153,183)(H,163,164)(H,165,166)(H,167,168)(H,188,189)(H4,128,129,132)(H4,130,131,133)/t64-,65+,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,96-,97-,98-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.82 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 313: 1397-405 (2005)
Article DOI: 10.1124/jpet.104.081497
BindingDB Entry DOI: 10.7270/Q2WD3Z5S |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85981
([ala1,leu13]pMOT(1-14) | [leu13]pMOT(1-14))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C82H124N20O20/c1-10-46(8)67(100-78(119)61-24-18-36-102(61)81(122)66(45(6)7)99-70(111)52(83)39-48-19-13-11-14-20-48)79(120)98-60(40-49-21-15-12-16-22-49)77(118)101-68(47(9)103)80(121)97-59(41-50-25-27-51(104)28-26-50)71(112)90-42-64(107)91-55(31-34-65(108)109)73(114)96-58(38-44(4)5)76(117)94-56(30-33-63(85)106)74(115)93-54(23-17-35-89-82(87)88)72(113)95-57(37-43(2)3)75(116)92-53(69(86)110)29-32-62(84)105/h11-16,19-22,25-28,43-47,52-61,66-68,103-104H,10,17-18,23-24,29-42,83H2,1-9H3,(H2,84,105)(H2,85,106)(H2,86,110)(H,90,112)(H,91,107)(H,92,116)(H,93,115)(H,94,117)(H,95,113)(H,96,114)(H,97,121)(H,98,120)(H,99,111)(H,100,119)(H,101,118)(H,108,109)(H4,87,88,89)/t46-,47+,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,66-,67-,68-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.16 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85614
([Leu13]motilin | [leu13]pMOT(1-22))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r| Show InChI InChI=1S/C121H190N34O35/c1-10-65(8)98(153-115(185)87-32-23-53-155(87)118(188)97(64(6)7)152-100(170)71(124)56-67-24-13-11-14-25-67)116(186)151-85(57-68-26-15-12-16-27-68)114(184)154-99(66(9)156)117(187)150-84(58-69-33-35-70(157)36-34-69)102(172)136-60-92(162)137-76(40-46-94(164)165)106(176)148-83(55-63(4)5)112(182)145-77(37-43-88(125)158)107(177)141-74(30-21-51-133-120(129)130)104(174)147-82(54-62(2)3)111(181)146-78(38-44-89(126)159)108(178)144-80(42-48-96(168)169)109(179)140-73(29-18-20-50-123)103(173)143-79(41-47-95(166)167)110(180)142-75(31-22-52-134-121(131)132)105(175)149-86(59-91(128)161)113(183)139-72(28-17-19-49-122)101(171)135-61-93(163)138-81(119(189)190)39-45-90(127)160/h11-16,24-27,33-36,62-66,71-87,97-99,156-157H,10,17-23,28-32,37-61,122-124H2,1-9H3,(H2,125,158)(H2,126,159)(H2,127,160)(H2,128,161)(H,135,171)(H,136,172)(H,137,162)(H,138,163)(H,139,183)(H,140,179)(H,141,177)(H,142,180)(H,143,173)(H,144,178)(H,145,182)(H,146,181)(H,147,174)(H,148,176)(H,149,175)(H,150,187)(H,151,186)(H,152,170)(H,153,185)(H,154,184)(H,164,165)(H,166,167)(H,168,169)(H,189,190)(H4,129,130,133)(H4,131,132,134)/t65-,66+,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,97-,98-,99-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sanwa Kagaku Kenkyusho Co., Ltd.
Curated by PDSP Ki Database
| |
Pharmacology 60: 128-35 (2000)
Article DOI: 28357
BindingDB Entry DOI: 10.7270/Q2RV0M7N |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85986
([ala11,leu13]pMOT(1-14))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C80H121N19O19/c1-11-45(8)65(97-76(115)60-25-19-35-99(60)79(118)64(44(6)7)96-69(108)52(81)38-48-20-14-12-15-21-48)77(116)95-59(39-49-22-16-13-17-23-49)75(114)98-66(47(10)100)78(117)94-58(40-50-26-28-51(101)29-27-50)70(109)87-41-62(103)89-55(31-33-63(104)105)72(111)92-56(36-42(2)3)73(112)88-46(9)68(107)91-54(24-18-34-86-80(84)85)71(110)93-57(37-43(4)5)74(113)90-53(67(83)106)30-32-61(82)102/h12-17,20-23,26-29,42-47,52-60,64-66,100-101H,11,18-19,24-25,30-41,81H2,1-10H3,(H2,82,102)(H2,83,106)(H,87,109)(H,88,112)(H,89,103)(H,90,113)(H,91,107)(H,92,111)(H,93,110)(H,94,117)(H,95,116)(H,96,108)(H,97,115)(H,98,114)(H,104,105)(H4,84,85,86)/t45-,46-,47+,52-,53-,54-,55-,56-,57-,58-,59-,60-,64-,65-,66-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 4.57 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85992
([ala10,leu13]pMOT(1-14))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C79H118N20O20/c1-9-43(6)64(97-75(116)58-23-17-35-99(58)78(119)63(42(4)5)96-68(109)50(80)37-46-18-12-10-13-19-46)76(117)95-57(38-47-20-14-11-15-21-47)74(115)98-65(45(8)100)77(118)94-56(39-48-24-26-49(101)27-25-48)69(110)87-40-61(104)89-53(30-33-62(105)106)70(111)88-44(7)67(108)91-54(29-32-60(82)103)72(113)92-52(22-16-34-86-79(84)85)71(112)93-55(36-41(2)3)73(114)90-51(66(83)107)28-31-59(81)102/h10-15,18-21,24-27,41-45,50-58,63-65,100-101H,9,16-17,22-23,28-40,80H2,1-8H3,(H2,81,102)(H2,82,103)(H2,83,107)(H,87,110)(H,88,111)(H,89,104)(H,90,114)(H,91,108)(H,92,113)(H,93,112)(H,94,118)(H,95,117)(H,96,109)(H,97,116)(H,98,115)(H,105,106)(H4,84,85,86)/t43-,44-,45+,50-,51-,52-,53-,54-,55-,56-,57-,58-,63-,64-,65-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85389
(CAS_52906-92-0 | Motilin)Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#16]-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r| Show InChI InChI=1S/C120H188N34O35S/c1-9-64(6)97(152-114(184)86-31-22-53-154(86)117(187)96(63(4)5)151-99(169)70(123)56-66-23-12-10-13-24-66)115(185)150-84(57-67-25-14-11-15-26-67)113(183)153-98(65(7)155)116(186)149-83(58-68-32-34-69(156)35-33-68)101(171)135-60-91(161)136-75(39-45-93(163)164)105(175)147-82(55-62(2)3)111(181)145-77(37-43-88(125)158)106(176)140-73(29-20-51-132-119(128)129)103(173)146-80(48-54-190-8)110(180)142-76(36-42-87(124)157)107(177)144-79(41-47-95(167)168)108(178)139-72(28-17-19-50-122)102(172)143-78(40-46-94(165)166)109(179)141-74(30-21-52-133-120(130)131)104(174)148-85(59-90(127)160)112(182)138-71(27-16-18-49-121)100(170)134-61-92(162)137-81(118(188)189)38-44-89(126)159/h10-15,23-26,32-35,62-65,70-86,96-98,155-156H,9,16-22,27-31,36-61,121-123H2,1-8H3,(H2,124,157)(H2,125,158)(H2,126,159)(H2,127,160)(H,134,170)(H,135,171)(H,136,161)(H,137,162)(H,138,182)(H,139,178)(H,140,176)(H,141,179)(H,142,180)(H,143,172)(H,144,177)(H,145,181)(H,146,173)(H,147,175)(H,148,174)(H,149,186)(H,150,185)(H,151,169)(H,152,184)(H,153,183)(H,163,164)(H,165,166)(H,167,168)(H,188,189)(H4,128,129,132)(H4,130,131,133)/t64-,65+,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,96-,97-,98-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Kosan Biosciences, Inc.
Curated by PDSP Ki Database
| |
Anal Biochem 300: 146-51 (2002)
Article DOI: 10.1006/abio.2001.5466
BindingDB Entry DOI: 10.7270/Q2NK3CM4 |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85989
(N-ethyl, N-methyl Erythromycin-A enol ether)Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)CC)[C@@]2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@]1(C)O |r,wU:37.39,25.25,48.53,6.6,44.47,46.49,12.13,30.34,10.9,16.16,27.28,wD:8.8,23.24,48.52,31.33,21.22,12.12,2.1,18.18,c:43,(-6.58,-.4,;-6.58,1.13,;-5.23,1.91,;-3.9,1.13,;-3.9,-.4,;-5.23,-1.2,;-2.57,-1.2,;-2.57,-2.73,;-1.22,-.4,;.11,-1.2,;.11,-2.73,;1.44,-3.5,;1.44,-5.03,;2.99,-5.03,;2.19,-6.39,;3.75,-6.39,;.11,-5.81,;.11,-7.36,;-1.22,-5.03,;-2.57,-5.81,;-1.22,-3.5,;-1.22,1.13,;-2.57,1.91,;.11,1.91,;1.44,1.13,;2.77,1.91,;4.1,1.13,;5.45,1.91,;6.78,1.13,;5.45,3.44,;4.1,4.21,;2.77,3.44,;1.44,4.21,;4.1,5.76,;2.77,6.52,;5.45,6.52,;6.79,5.75,;.11,3.44,;1.64,3.44,;.44,4.9,;-.44,6.16,;.55,7.36,;-2.33,6.72,;-1.88,4.46,;-3.9,5.76,;-5.23,6.52,;-3.9,4.21,;-2.57,3.44,;-5.23,3.44,;-6.78,3.44,;-6.01,4.79,)| Show InChI InChI=1S/C38H67NO12/c1-14-26-38(11,44)31(41)21(5)29-19(3)17-37(10,51-29)33(50-35-28(40)25(39(12)15-2)16-20(4)46-35)22(6)30(23(7)34(43)48-26)49-27-18-36(9,45-13)32(42)24(8)47-27/h20-28,30-33,35,40-42,44H,14-18H2,1-13H3/t20-,21+,22+,23-,24+,25+,26-,27+,28-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 6.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85980
([ala12,leu13]pMOT(1-14))Show SMILES CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(N)=O |r| Show InChI InChI=1S/C79H117N17O20/c1-11-44(8)65(94-76(113)59-23-18-34-96(59)79(116)64(43(6)7)93-69(106)51(80)37-47-19-14-12-15-20-47)77(114)92-58(38-48-21-16-13-17-22-48)75(112)95-66(46(10)97)78(115)91-57(39-49-24-26-50(98)27-25-49)70(107)84-40-62(101)86-53(30-33-63(102)103)72(109)90-56(36-42(4)5)74(111)88-54(29-32-61(82)100)71(108)85-45(9)68(105)89-55(35-41(2)3)73(110)87-52(67(83)104)28-31-60(81)99/h12-17,19-22,24-27,41-46,51-59,64-66,97-98H,11,18,23,28-40,80H2,1-10H3,(H2,81,99)(H2,82,100)(H2,83,104)(H,84,107)(H,85,108)(H,86,101)(H,87,110)(H,88,111)(H,89,105)(H,90,109)(H,91,115)(H,92,114)(H,93,106)(H,94,113)(H,95,112)(H,102,103)/t44-,45-,46+,51-,52-,53-,54-,55-,56-,57-,58-,59-,64-,65-,66-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 6.31 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85999
([ala14,leu13]pMOT(1-14))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6])-[#6](-[#7])=O |r| Show InChI InChI=1S/C80H121N19O19/c1-11-45(8)65(97-76(115)60-25-19-35-99(60)79(118)64(44(6)7)96-68(107)52(81)38-48-20-14-12-15-21-48)77(116)95-59(39-49-22-16-13-17-23-49)75(114)98-66(47(10)100)78(117)94-58(40-50-26-28-51(101)29-27-50)69(108)87-41-62(103)89-54(31-33-63(104)105)71(110)93-57(37-43(4)5)74(113)91-55(30-32-61(82)102)72(111)90-53(24-18-34-86-80(84)85)70(109)92-56(36-42(2)3)73(112)88-46(9)67(83)106/h12-17,20-23,26-29,42-47,52-60,64-66,100-101H,11,18-19,24-25,30-41,81H2,1-10H3,(H2,82,102)(H2,83,106)(H,87,108)(H,88,112)(H,89,103)(H,90,111)(H,91,113)(H,92,109)(H,93,110)(H,94,117)(H,95,116)(H,96,107)(H,97,115)(H,98,114)(H,104,105)(H4,84,85,86)/t45-,46-,47+,52-,53-,54-,55-,56-,57-,58-,59-,60-,64-,65-,66-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 7.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85990
([ala13,leu13]pMOT(1-14))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C79H118N20O20/c1-9-43(6)64(97-75(116)58-23-17-35-99(58)78(119)63(42(4)5)96-68(109)50(80)37-46-18-12-10-13-19-46)76(117)95-57(38-47-20-14-11-15-21-47)74(115)98-65(45(8)100)77(118)94-56(39-48-24-26-49(101)27-25-48)69(110)87-40-61(104)89-53(30-33-62(105)106)71(112)93-55(36-41(2)3)73(114)92-54(29-32-60(82)103)72(113)91-52(22-16-34-86-79(84)85)70(111)88-44(7)67(108)90-51(66(83)107)28-31-59(81)102/h10-15,18-21,24-27,41-45,50-58,63-65,100-101H,9,16-17,22-23,28-40,80H2,1-8H3,(H2,81,102)(H2,82,103)(H2,83,107)(H,87,110)(H,88,111)(H,89,104)(H,90,108)(H,91,113)(H,92,114)(H,93,112)(H,94,118)(H,95,117)(H,96,109)(H,97,116)(H,98,115)(H,105,106)(H4,84,85,86)/t43-,44-,45+,50-,51-,52-,53-,54-,55-,56-,57-,58-,63-,64-,65-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 7.24 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85993
(Erythromycin-B enol ether)Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)C2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@H]1C |wU:23.24,25.25,8.8,30.34,21.22,12.12,18.18,27.28,47.51,2.1,wD:10.9,12.13,31.33,16.16,45.48,6.6,43.46,c:42,(3.08,2.25,;4.62,2.25,;5.39,.92,;6.93,.92,;7.7,2.25,;6.93,3.59,;9.24,2.25,;10.01,3.59,;10.01,.92,;11.55,.92,;12.32,2.25,;13.86,2.25,;14.63,3.59,;15.96,2.82,;15.96,4.36,;17.3,3.59,;13.86,4.92,;14.63,6.26,;12.32,4.92,;11.55,6.26,;11.55,3.59,;9.24,-.41,;7.91,.36,;10.01,-1.75,;11.55,-1.75,;12.32,-3.08,;11.55,-4.41,;12.32,-5.75,;11.55,-7.08,;13.86,-5.75,;14.63,-4.41,;13.86,-3.08,;14.63,-1.75,;16.17,-4.41,;16.94,-5.75,;16.94,-3.08,;9.24,-3.08,;10.73,-3.48,;8.84,-4.57,;6.72,-5.18,;5.95,-6.52,;5.39,-4.41,;6.82,-2.69,;4.62,-3.08,;3.08,-3.08,;5.39,-1.75,;6.93,-1.75,;4.62,-.41,;3.08,-.41,)| Show InChI InChI=1S/C37H65NO11/c1-14-26-20(4)28(39)21(5)30-18(2)16-37(10,49-30)33(48-35-29(40)25(38(11)12)15-19(3)44-35)22(6)31(23(7)34(42)46-26)47-27-17-36(9,43-13)32(41)24(8)45-27/h19-29,31-33,35,39-41H,14-17H2,1-13H3/t19-,20+,21-,22+,23-,24+,25+,26-,27+,28+,29-,31+,32+,33-,35+,36-,37?/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 7.59 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85846
(CAS_33396-29-1 | EM523 | Erythromycin A 6,9-enolet...)Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@]2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@]1(C)O |r,wU:36.38,25.25,47.52,6.6,43.46,45.48,12.13,30.34,10.9,16.16,27.28,wD:8.8,23.24,47.51,31.33,21.22,12.12,2.1,18.18,c:42,(-6.58,-.4,;-6.58,1.13,;-5.23,1.91,;-3.9,1.13,;-3.9,-.4,;-5.23,-1.2,;-2.57,-1.2,;-2.57,-2.73,;-1.22,-.4,;.11,-1.2,;.11,-2.73,;1.44,-3.5,;1.44,-5.03,;2.99,-5.03,;2.19,-6.39,;3.75,-6.39,;.11,-5.81,;.11,-7.36,;-1.22,-5.03,;-2.57,-5.81,;-1.22,-3.5,;-1.22,1.13,;-2.57,1.91,;.11,1.91,;1.44,1.13,;2.77,1.91,;4.1,1.13,;5.45,1.91,;6.78,1.13,;5.45,3.44,;4.1,4.21,;2.77,3.44,;1.44,4.21,;4.1,5.76,;2.77,6.52,;5.45,6.52,;.11,3.44,;1.64,3.44,;.44,4.9,;-.44,6.16,;.55,7.36,;-2.33,6.72,;-1.88,4.46,;-3.9,5.76,;-5.23,6.52,;-3.9,4.21,;-2.57,3.44,;-5.23,3.44,;-6.78,3.44,;-6.01,4.79,)| Show InChI InChI=1S/C37H65NO12/c1-14-25-37(10,43)30(40)20(4)28-18(2)16-36(9,50-28)32(49-34-27(39)24(38(11)12)15-19(3)45-34)21(5)29(22(6)33(42)47-25)48-26-17-35(8,44-13)31(41)23(7)46-26/h19-27,29-32,34,39-41,43H,14-17H2,1-13H3/t19-,20+,21+,22-,23+,24+,25-,26+,27-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 8.32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85846
(CAS_33396-29-1 | EM523 | Erythromycin A 6,9-enolet...)Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@]2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@]1(C)O |r,wU:36.38,25.25,47.52,6.6,43.46,45.48,12.13,30.34,10.9,16.16,27.28,wD:8.8,23.24,47.51,31.33,21.22,12.12,2.1,18.18,c:42,(-6.58,-.4,;-6.58,1.13,;-5.23,1.91,;-3.9,1.13,;-3.9,-.4,;-5.23,-1.2,;-2.57,-1.2,;-2.57,-2.73,;-1.22,-.4,;.11,-1.2,;.11,-2.73,;1.44,-3.5,;1.44,-5.03,;2.99,-5.03,;2.19,-6.39,;3.75,-6.39,;.11,-5.81,;.11,-7.36,;-1.22,-5.03,;-2.57,-5.81,;-1.22,-3.5,;-1.22,1.13,;-2.57,1.91,;.11,1.91,;1.44,1.13,;2.77,1.91,;4.1,1.13,;5.45,1.91,;6.78,1.13,;5.45,3.44,;4.1,4.21,;2.77,3.44,;1.44,4.21,;4.1,5.76,;2.77,6.52,;5.45,6.52,;.11,3.44,;1.64,3.44,;.44,4.9,;-.44,6.16,;.55,7.36,;-2.33,6.72,;-1.88,4.46,;-3.9,5.76,;-5.23,6.52,;-3.9,4.21,;-2.57,3.44,;-5.23,3.44,;-6.78,3.44,;-6.01,4.79,)| Show InChI InChI=1S/C37H65NO12/c1-14-25-37(10,43)30(40)20(4)28-18(2)16-36(9,50-28)32(49-34-27(39)24(38(11)12)15-19(3)45-34)21(5)29(22(6)33(42)47-25)48-26-17-35(8,44-13)31(41)23(7)46-26/h19-27,29-32,34,39-41,43H,14-17H2,1-13H3/t19-,20+,21+,22-,23+,24+,25-,26+,27-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 19.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Kosan Biosciences, Inc.
Curated by PDSP Ki Database
| |
Anal Biochem 300: 146-51 (2002)
Article DOI: 10.1006/abio.2001.5466
BindingDB Entry DOI: 10.7270/Q2NK3CM4 |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85984
([ala5,leu13]pMOT(1-14))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C76H120N20O20/c1-11-41(8)61(94-72(113)55-20-16-32-96(55)75(116)60(40(6)7)93-65(106)47(77)35-44-17-13-12-14-18-44)73(114)85-42(9)64(105)95-62(43(10)97)74(115)92-54(36-45-21-23-46(98)24-22-45)66(107)84-37-58(101)86-50(27-30-59(102)103)68(109)91-53(34-39(4)5)71(112)89-51(26-29-57(79)100)69(110)88-49(19-15-31-83-76(81)82)67(108)90-52(33-38(2)3)70(111)87-48(63(80)104)25-28-56(78)99/h12-14,17-18,21-24,38-43,47-55,60-62,97-98H,11,15-16,19-20,25-37,77H2,1-10H3,(H2,78,99)(H2,79,100)(H2,80,104)(H,84,107)(H,85,114)(H,86,101)(H,87,111)(H,88,110)(H,89,112)(H,90,108)(H,91,109)(H,92,115)(H,93,106)(H,94,113)(H,95,105)(H,102,103)(H4,81,82,83)/t41-,42-,43+,47-,48-,49-,50-,51-,52-,53-,54-,55-,60-,61-,62-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 28.8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85983
([ala8,leu13]pMOT(1-14))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6@@H](-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C83H126N20O20/c1-11-46(8)67(101-79(120)62-25-19-37-103(62)82(123)66(45(6)7)100-71(112)53(84)40-49-20-14-12-15-21-49)80(121)98-61(41-50-22-16-13-17-23-50)78(119)102-68(48(10)104)81(122)99-60(42-51-26-28-52(105)29-27-51)75(116)91-47(9)70(111)93-57(32-35-65(108)109)74(115)97-59(39-44(4)5)77(118)95-56(31-34-64(86)107)73(114)94-55(24-18-36-90-83(88)89)72(113)96-58(38-43(2)3)76(117)92-54(69(87)110)30-33-63(85)106/h12-17,20-23,26-29,43-48,53-62,66-68,104-105H,11,18-19,24-25,30-42,84H2,1-10H3,(H2,85,106)(H2,86,107)(H2,87,110)(H,91,116)(H,92,117)(H,93,111)(H,94,114)(H,95,118)(H,96,113)(H,97,115)(H,98,121)(H,99,122)(H,100,112)(H,101,120)(H,102,119)(H,108,109)(H4,88,89,90)/t46-,47-,48+,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,66-,67-,68-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 36.3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85978
([ala6,leu13]pMOT(1-14))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C81H122N20O19/c1-10-46(8)67(100-78(118)61-24-18-36-101(61)80(120)66(45(6)7)99-70(110)52(82)39-48-19-13-11-14-20-48)79(119)98-60(40-49-21-15-12-16-22-49)75(115)90-47(9)69(109)95-59(41-50-25-27-51(102)28-26-50)71(111)89-42-64(105)91-55(31-34-65(106)107)73(113)97-58(38-44(4)5)77(117)94-56(30-33-63(84)104)74(114)93-54(23-17-35-88-81(86)87)72(112)96-57(37-43(2)3)76(116)92-53(68(85)108)29-32-62(83)103/h11-16,19-22,25-28,43-47,52-61,66-67,102H,10,17-18,23-24,29-42,82H2,1-9H3,(H2,83,103)(H2,84,104)(H2,85,108)(H,89,111)(H,90,115)(H,91,105)(H,92,116)(H,93,114)(H,94,117)(H,95,109)(H,96,112)(H,97,113)(H,98,119)(H,99,110)(H,100,118)(H,106,107)(H4,86,87,88)/t46-,47-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,66-,67-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 46.8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85846
(CAS_33396-29-1 | EM523 | Erythromycin A 6,9-enolet...)Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@]2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@]1(C)O |r,wU:36.38,25.25,47.52,6.6,43.46,45.48,12.13,30.34,10.9,16.16,27.28,wD:8.8,23.24,47.51,31.33,21.22,12.12,2.1,18.18,c:42,(-6.58,-.4,;-6.58,1.13,;-5.23,1.91,;-3.9,1.13,;-3.9,-.4,;-5.23,-1.2,;-2.57,-1.2,;-2.57,-2.73,;-1.22,-.4,;.11,-1.2,;.11,-2.73,;1.44,-3.5,;1.44,-5.03,;2.99,-5.03,;2.19,-6.39,;3.75,-6.39,;.11,-5.81,;.11,-7.36,;-1.22,-5.03,;-2.57,-5.81,;-1.22,-3.5,;-1.22,1.13,;-2.57,1.91,;.11,1.91,;1.44,1.13,;2.77,1.91,;4.1,1.13,;5.45,1.91,;6.78,1.13,;5.45,3.44,;4.1,4.21,;2.77,3.44,;1.44,4.21,;4.1,5.76,;2.77,6.52,;5.45,6.52,;.11,3.44,;1.64,3.44,;.44,4.9,;-.44,6.16,;.55,7.36,;-2.33,6.72,;-1.88,4.46,;-3.9,5.76,;-5.23,6.52,;-3.9,4.21,;-2.57,3.44,;-5.23,3.44,;-6.78,3.44,;-6.01,4.79,)| Show InChI InChI=1S/C37H65NO12/c1-14-25-37(10,43)30(40)20(4)28-18(2)16-36(9,50-28)32(49-34-27(39)24(38(11)12)15-19(3)45-34)21(5)29(22(6)33(42)47-25)48-26-17-35(8,44-13)31(41)23(7)46-26/h19-27,29-32,34,39-41,43H,14-17H2,1-13H3/t19-,20+,21+,22-,23+,24+,25-,26+,27-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 47.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Kosan Biosciences, Inc.
Curated by PDSP Ki Database
| |
Anal Biochem 300: 146-51 (2002)
Article DOI: 10.1006/abio.2001.5466
BindingDB Entry DOI: 10.7270/Q2NK3CM4 |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86675
(CAS_0 | NSC_0 | [Bpa5,Ile13]Motilin | [L-Bpa5,Ile1...)Show SMILES [#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(-[#8])cc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(cc1)-[#6](=O)-c1ccccc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6@@H](-[#6])-[#6]-[#6])-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#6])=[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r,w:127.132| Show InChI InChI=1S/C129H196N34O35/c1-11-69(7)105(123(193)148-80(43-49-95(133)166)71(9)145-85(46-52-101(172)173)114(184)150-82(31-20-22-56-131)112(182)153-88(48-54-103(176)177)117(187)151-83(32-23-57-141-128(137)138)113(183)156-93(64-98(136)169)120(190)149-81(30-19-21-55-130)110(180)143-66-100(171)147-89(127(197)198)45-51-97(135)168)160-118(188)84(33-24-58-142-129(139)140)152-116(186)87(44-50-96(134)167)154-119(189)90(60-67(3)4)155-115(185)86(47-53-102(174)175)146-99(170)65-144-111(181)91(62-75-37-41-78(165)42-38-75)157-125(195)107(72(10)164)162-121(191)92(63-74-35-39-77(40-36-74)108(178)76-28-17-14-18-29-76)158-124(194)106(70(8)12-2)161-122(192)94-34-25-59-163(94)126(196)104(68(5)6)159-109(179)79(132)61-73-26-15-13-16-27-73/h13-18,26-29,35-42,67-70,72,79-94,104-107,164-165H,11-12,19-25,30-34,43-66,130-132H2,1-10H3,(H2,133,166)(H2,134,167)(H2,135,168)(H2,136,169)(H,143,180)(H,144,181)(H,146,170)(H,147,171)(H,148,193)(H,149,190)(H,150,184)(H,151,187)(H,152,186)(H,153,182)(H,154,189)(H,155,185)(H,156,183)(H,157,195)(H,158,194)(H,159,179)(H,160,188)(H,161,192)(H,162,191)(H,172,173)(H,174,175)(H,176,177)(H,197,198)(H4,137,138,141)(H4,139,140,142)/t69?,70-,72+,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,104-,105-,106-,107-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Mayo Clinic in Scottsdale
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 313: 1101-8 (2005)
Article DOI: 10.1124/jpet.104.081562
BindingDB Entry DOI: 10.7270/Q28K77N1 |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86675
(CAS_0 | NSC_0 | [Bpa5,Ile13]Motilin | [L-Bpa5,Ile1...)Show SMILES [#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(-[#8])cc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(cc1)-[#6](=O)-c1ccccc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6@@H](-[#6])-[#6]-[#6])-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#6])=[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r,w:127.132| Show InChI InChI=1S/C129H196N34O35/c1-11-69(7)105(123(193)148-80(43-49-95(133)166)71(9)145-85(46-52-101(172)173)114(184)150-82(31-20-22-56-131)112(182)153-88(48-54-103(176)177)117(187)151-83(32-23-57-141-128(137)138)113(183)156-93(64-98(136)169)120(190)149-81(30-19-21-55-130)110(180)143-66-100(171)147-89(127(197)198)45-51-97(135)168)160-118(188)84(33-24-58-142-129(139)140)152-116(186)87(44-50-96(134)167)154-119(189)90(60-67(3)4)155-115(185)86(47-53-102(174)175)146-99(170)65-144-111(181)91(62-75-37-41-78(165)42-38-75)157-125(195)107(72(10)164)162-121(191)92(63-74-35-39-77(40-36-74)108(178)76-28-17-14-18-29-76)158-124(194)106(70(8)12-2)161-122(192)94-34-25-59-163(94)126(196)104(68(5)6)159-109(179)79(132)61-73-26-15-13-16-27-73/h13-18,26-29,35-42,67-70,72,79-94,104-107,164-165H,11-12,19-25,30-34,43-66,130-132H2,1-10H3,(H2,133,166)(H2,134,167)(H2,135,168)(H2,136,169)(H,143,180)(H,144,181)(H,146,170)(H,147,171)(H,148,193)(H,149,190)(H,150,184)(H,151,187)(H,152,186)(H,153,182)(H,154,189)(H,155,185)(H,156,183)(H,157,195)(H,158,194)(H,159,179)(H,160,188)(H,161,192)(H,162,191)(H,172,173)(H,174,175)(H,176,177)(H,197,198)(H4,137,138,141)(H4,139,140,142)/t69?,70-,72+,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,104-,105-,106-,107-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Mayo Clinic in Scottsdale
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 313: 1101-8 (2005)
Article DOI: 10.1124/jpet.104.081562
BindingDB Entry DOI: 10.7270/Q28K77N1 |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86685
(ABT-229)Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@](C)(C[C@H](C)O2)OC)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)CC)[C@@]2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@H]1C |c:42| Show InChI InChI=1S/C38H67NO10/c1-14-28-23(6)30(40)24(7)32-20(3)17-38(11,49-32)34(48-36-31(41)27(39(12)15-2)16-21(4)45-36)25(8)33(26(9)35(42)46-28)47-29-19-37(10,43-13)18-22(5)44-29/h21-31,33-34,36,40-41H,14-19H2,1-13H3/t21-,22+,23+,24-,25+,26-,27+,28-,29+,30+,31-,33+,34-,36+,37+,38-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 58.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 313: 1397-405 (2005)
Article DOI: 10.1124/jpet.104.081497
BindingDB Entry DOI: 10.7270/Q2WD3Z5S |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85991
([ala9,leu13]pMOT(1-14))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C80H122N20O18/c1-11-45(8)65(98-76(115)60-25-19-35-100(60)79(118)64(44(6)7)97-69(108)52(81)38-48-20-14-12-15-21-48)77(116)96-59(39-49-22-16-13-17-23-49)75(114)99-66(47(10)101)78(117)95-58(40-50-26-28-51(102)29-27-50)70(109)88-41-63(105)89-46(9)68(107)93-56(36-42(2)3)74(113)92-55(31-33-62(83)104)72(111)91-54(24-18-34-87-80(85)86)71(110)94-57(37-43(4)5)73(112)90-53(67(84)106)30-32-61(82)103/h12-17,20-23,26-29,42-47,52-60,64-66,101-102H,11,18-19,24-25,30-41,81H2,1-10H3,(H2,82,103)(H2,83,104)(H2,84,106)(H,88,109)(H,89,105)(H,90,112)(H,91,111)(H,92,113)(H,93,107)(H,94,110)(H,95,117)(H,96,116)(H,97,108)(H,98,115)(H,99,114)(H4,85,86,87)/t45-,46-,47+,52-,53-,54-,55-,56-,57-,58-,59-,60-,64-,65-,66-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 75.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85995
([leu13]pMOT(1-11))Show SMILES CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(N)=O |r| Show InChI InChI=1S/C65H93N13O16/c1-8-37(6)54(76-62(91)49-20-15-29-78(49)65(94)53(36(4)5)75-57(86)43(66)31-39-16-11-9-12-17-39)63(92)74-48(32-40-18-13-10-14-19-40)61(90)77-55(38(7)79)64(93)73-47(33-41-21-23-42(80)24-22-41)58(87)69-34-51(82)70-45(26-28-52(83)84)59(88)72-46(30-35(2)3)60(89)71-44(56(68)85)25-27-50(67)81/h9-14,16-19,21-24,35-38,43-49,53-55,79-80H,8,15,20,25-34,66H2,1-7H3,(H2,67,81)(H2,68,85)(H,69,87)(H,70,82)(H,71,89)(H,72,88)(H,73,93)(H,74,92)(H,75,86)(H,76,91)(H,77,90)(H,83,84)/t37-,38+,43-,44-,45-,46-,47-,48-,49-,53-,54-,55-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 89.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85998
(Erythromycin-B)Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H]1C Show InChI InChI=1S/C37H67NO12/c1-14-26-20(4)29(40)21(5)28(39)18(2)16-36(9,44)33(50-35-30(41)25(38(11)12)15-19(3)46-35)22(6)31(23(7)34(43)48-26)49-27-17-37(10,45-13)32(42)24(8)47-27/h18-27,29-33,35,40-42,44H,14-17H2,1-13H3/t18-,19-,20+,21+,22+,23-,24+,25+,26-,27+,29+,30-,31+,32+,33-,35+,36-,37-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
KEGG
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| 145 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85988
(N-ethyl, N-Methyl Erythromycin-A)Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)CC)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O Show InChI InChI=1S/C38H69NO13/c1-14-26-38(11,46)31(42)21(5)28(40)19(3)17-36(9,45)33(52-35-29(41)25(39(12)15-2)16-20(4)48-35)22(6)30(23(7)34(44)50-26)51-27-18-37(10,47-13)32(43)24(8)49-27/h19-27,29-33,35,41-43,45-46H,14-18H2,1-13H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 240 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85846
(CAS_33396-29-1 | EM523 | Erythromycin A 6,9-enolet...)Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@]2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@]1(C)O |r,wU:36.38,25.25,47.52,6.6,43.46,45.48,12.13,30.34,10.9,16.16,27.28,wD:8.8,23.24,47.51,31.33,21.22,12.12,2.1,18.18,c:42,(-6.58,-.4,;-6.58,1.13,;-5.23,1.91,;-3.9,1.13,;-3.9,-.4,;-5.23,-1.2,;-2.57,-1.2,;-2.57,-2.73,;-1.22,-.4,;.11,-1.2,;.11,-2.73,;1.44,-3.5,;1.44,-5.03,;2.99,-5.03,;2.19,-6.39,;3.75,-6.39,;.11,-5.81,;.11,-7.36,;-1.22,-5.03,;-2.57,-5.81,;-1.22,-3.5,;-1.22,1.13,;-2.57,1.91,;.11,1.91,;1.44,1.13,;2.77,1.91,;4.1,1.13,;5.45,1.91,;6.78,1.13,;5.45,3.44,;4.1,4.21,;2.77,3.44,;1.44,4.21,;4.1,5.76,;2.77,6.52,;5.45,6.52,;.11,3.44,;1.64,3.44,;.44,4.9,;-.44,6.16,;.55,7.36,;-2.33,6.72,;-1.88,4.46,;-3.9,5.76,;-5.23,6.52,;-3.9,4.21,;-2.57,3.44,;-5.23,3.44,;-6.78,3.44,;-6.01,4.79,)| Show InChI InChI=1S/C37H65NO12/c1-14-25-37(10,43)30(40)20(4)28-18(2)16-36(9,50-28)32(49-34-27(39)24(38(11)12)15-19(3)45-34)21(5)29(22(6)33(42)47-25)48-26-17-35(8,44-13)31(41)23(7)46-26/h19-27,29-32,34,39-41,43H,14-17H2,1-13H3/t19-,20+,21+,22-,23+,24+,25-,26+,27-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 257 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 313: 1397-405 (2005)
Article DOI: 10.1124/jpet.104.081497
BindingDB Entry DOI: 10.7270/Q2WD3Z5S |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86688
(EM-B enolether)Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@]2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@@H]1C |c:42| Show InChI InChI=1S/C37H65NO11/c1-14-26-20(4)28(39)21(5)30-18(2)16-37(10,49-30)33(48-35-29(40)25(38(11)12)15-19(3)44-35)22(6)31(23(7)34(42)46-26)47-27-17-36(9,43-13)32(41)24(8)45-27/h19-29,31-33,35,39-41H,14-17H2,1-13H3/t19-,20-,21-,22+,23-,24+,25+,26-,27+,28+,29-,31+,32+,33-,35+,36-,37+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 324 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 313: 1397-405 (2005)
Article DOI: 10.1124/jpet.104.081497
BindingDB Entry DOI: 10.7270/Q2WD3Z5S |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86676
([D-Bpa5,Ile13]Motilin)Show SMILES [#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(-[#8])cc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#6]-c1ccc(cc1)-[#6](=O)-c1ccccc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6@@H](-[#6])-[#6]-[#6])-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#6])=[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#6]-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#8])=O |r,w:127.132| Show InChI InChI=1S/C129H196N34O35/c1-11-69(7)105(123(193)148-80(43-49-95(133)166)71(9)145-85(46-52-101(172)173)114(184)150-82(31-20-22-56-131)112(182)153-88(48-54-103(176)177)117(187)151-83(32-23-57-141-128(137)138)113(183)156-93(64-98(136)169)120(190)149-81(30-19-21-55-130)110(180)143-66-100(171)147-89(127(197)198)45-51-97(135)168)160-118(188)84(33-24-58-142-129(139)140)152-116(186)87(44-50-96(134)167)154-119(189)90(60-67(3)4)155-115(185)86(47-53-102(174)175)146-99(170)65-144-111(181)91(62-75-37-41-78(165)42-38-75)157-125(195)107(72(10)164)162-121(191)92(63-74-35-39-77(40-36-74)108(178)76-28-17-14-18-29-76)158-124(194)106(70(8)12-2)161-122(192)94-34-25-59-163(94)126(196)104(68(5)6)159-109(179)79(132)61-73-26-15-13-16-27-73/h13-18,26-29,35-42,67-70,72,79-94,104-107,164-165H,11-12,19-25,30-34,43-66,130-132H2,1-10H3,(H2,133,166)(H2,134,167)(H2,135,168)(H2,136,169)(H,143,180)(H,144,181)(H,146,170)(H,147,171)(H,148,193)(H,149,190)(H,150,184)(H,151,187)(H,152,186)(H,153,182)(H,154,189)(H,155,185)(H,156,183)(H,157,195)(H,158,194)(H,159,179)(H,160,188)(H,161,192)(H,162,191)(H,172,173)(H,174,175)(H,176,177)(H,197,198)(H4,137,138,141)(H4,139,140,142)/t69?,70-,72+,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92+,93-,94-,104-,105-,106-,107-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 420 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Mayo Clinic in Scottsdale
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 313: 1101-8 (2005)
Article DOI: 10.1124/jpet.104.081562
BindingDB Entry DOI: 10.7270/Q28K77N1 |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86313
(CAS_114-07-8 | NSC_12560 | erythromycin-A)Show SMILES CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(C2O)N(C)C)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O Show InChI InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| 513 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by PDSP Ki Database
| |
Br J Pharmacol 140: 948-54 (2003)
Article DOI: 10.1038/sj.bjp.0705505
BindingDB Entry DOI: 10.7270/Q2N58JZF |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86686
(Erythromycin A Enol Ether | ME4)Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N)[C@H]2O)[C@@]2(C)CC(C)=C(O2)[C@H](C)[C@@H](O)[C@]1(C)O |r,wU:34.36,25.25,45.50,6.6,41.44,43.46,12.13,30.31,10.9,16.16,27.28,wD:8.8,23.24,45.49,32.34,21.22,12.12,2.1,18.18,c:40,(-6.58,-.4,;-6.58,1.13,;-5.23,1.91,;-3.9,1.13,;-3.9,-.4,;-5.23,-1.2,;-2.57,-1.2,;-2.57,-2.73,;-1.22,-.4,;.11,-1.2,;.11,-2.73,;1.44,-3.5,;1.44,-5.03,;2.99,-5.03,;2.19,-6.39,;3.75,-6.39,;.11,-5.81,;.11,-7.36,;-1.22,-5.03,;-2.57,-5.81,;-1.22,-3.5,;-1.22,1.13,;-2.57,1.91,;.11,1.91,;1.44,1.13,;2.77,1.91,;4.1,1.13,;5.45,1.91,;6.78,1.13,;5.45,3.44,;4.1,4.21,;4.1,5.76,;2.77,3.44,;1.44,4.21,;.11,3.44,;1.64,3.44,;.44,4.9,;-.44,6.16,;.55,7.36,;-2.33,6.72,;-1.88,4.46,;-3.9,5.76,;-5.23,6.52,;-3.9,4.21,;-2.57,3.44,;-5.23,3.44,;-6.78,3.44,;-6.01,4.79,)| Show InChI InChI=1S/C35H61NO12/c1-12-23-35(10,41)28(38)18(4)26-16(2)14-34(9,48-26)30(47-32-25(37)22(36)13-17(3)43-32)19(5)27(20(6)31(40)45-23)46-24-15-33(8,42-11)29(39)21(7)44-24/h17-25,27-30,32,37-39,41H,12-15,36H2,1-11H3/t17-,18+,19+,20-,21+,22+,23-,24+,25-,27+,28-,29+,30-,32+,33-,34-,35-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 537 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 313: 1397-405 (2005)
Article DOI: 10.1124/jpet.104.081497
BindingDB Entry DOI: 10.7270/Q2WD3Z5S |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85981
([ala1,leu13]pMOT(1-14) | [leu13]pMOT(1-14))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C82H124N20O20/c1-10-46(8)67(100-78(119)61-24-18-36-102(61)81(122)66(45(6)7)99-70(111)52(83)39-48-19-13-11-14-20-48)79(120)98-60(40-49-21-15-12-16-22-49)77(118)101-68(47(9)103)80(121)97-59(41-50-25-27-51(104)28-26-50)71(112)90-42-64(107)91-55(31-34-65(108)109)73(114)96-58(38-44(4)5)76(117)94-56(30-33-63(85)106)74(115)93-54(23-17-35-89-82(87)88)72(113)95-57(37-43(2)3)75(116)92-53(69(86)110)29-32-62(84)105/h11-16,19-22,25-28,43-47,52-61,66-68,103-104H,10,17-18,23-24,29-42,83H2,1-9H3,(H2,84,105)(H2,85,106)(H2,86,110)(H,90,112)(H,91,107)(H,92,116)(H,93,115)(H,94,117)(H,95,113)(H,96,114)(H,97,121)(H,98,120)(H,99,111)(H,100,119)(H,101,118)(H,108,109)(H4,87,88,89)/t46-,47+,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,66-,67-,68-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 589 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM50127141
((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2R,3S,4R,...)Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]2O[C@@H](C)C[C@H]([C@@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O |r| Show InChI InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19+,20+,21+,22-,23+,24-,25-,26+,28+,29+,30-,31+,32-,34-,35-,36-,37-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MMDB
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.29E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Kosan Biosciences, Inc.
Curated by PDSP Ki Database
| |
Anal Biochem 300: 146-51 (2002)
Article DOI: 10.1006/abio.2001.5466
BindingDB Entry DOI: 10.7270/Q2NK3CM4 |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85982
([ala7,leu13]pMOT(1-14))Show SMILES [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#8])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C76H120N20O19/c1-11-42(8)61(94-72(112)55-25-19-33-96(55)75(115)60(41(6)7)93-65(105)47(77)36-45-20-14-12-15-21-45)73(113)92-54(37-46-22-16-13-17-23-46)71(111)95-62(44(10)97)74(114)85-43(9)64(104)84-38-58(100)86-50(28-31-59(101)102)67(107)91-53(35-40(4)5)70(110)89-51(27-30-57(79)99)68(108)88-49(24-18-32-83-76(81)82)66(106)90-52(34-39(2)3)69(109)87-48(63(80)103)26-29-56(78)98/h12-17,20-23,39-44,47-55,60-62,97H,11,18-19,24-38,77H2,1-10H3,(H2,78,98)(H2,79,99)(H2,80,103)(H,84,104)(H,85,114)(H,86,100)(H,87,109)(H,88,108)(H,89,110)(H,90,106)(H,91,107)(H,92,113)(H,93,105)(H,94,112)(H,95,111)(H,101,102)(H4,81,82,83)/t42-,43-,44+,47-,48-,49-,50-,51-,52-,53-,54-,55-,60-,61-,62-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.45E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86000
([ala4,leu13]pMOT(1-14))Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccc(-[#8])cc1)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@H](-[#6]-c1ccccc1)-[#7]-[#6](=O)-[#6@H](-[#6])-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](-[#6])-[#6])-[#6@@H](-[#6])-[#8])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](-[#7])=O |r| Show InChI InChI=1S/C79H118N20O20/c1-41(2)35-55(73(114)90-51(66(83)107)27-30-60(81)102)94-70(111)52(21-15-33-86-79(84)85)91-72(113)54(28-31-61(82)103)92-74(115)56(36-42(3)4)95-71(112)53(29-32-63(105)106)89-62(104)40-87-69(110)57(39-48-23-25-49(101)26-24-48)96-77(118)65(45(8)100)98-75(116)58(38-47-19-13-10-14-20-47)93-67(108)44(7)88-76(117)59-22-16-34-99(59)78(119)64(43(5)6)97-68(109)50(80)37-46-17-11-9-12-18-46/h9-14,17-20,23-26,41-45,50-59,64-65,100-101H,15-16,21-22,27-40,80H2,1-8H3,(H2,81,102)(H2,82,103)(H2,83,107)(H,87,110)(H,88,117)(H,89,104)(H,90,114)(H,91,113)(H,92,115)(H,93,108)(H,94,111)(H,95,112)(H,96,118)(H,97,109)(H,98,116)(H,105,106)(H4,84,85,86)/t44-,45+,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,64-,65-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.57E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86313
(CAS_114-07-8 | NSC_12560 | erythromycin-A)Show SMILES CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(C2O)N(C)C)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O Show InChI InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| 3.09E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 313: 1397-405 (2005)
Article DOI: 10.1124/jpet.104.081497
BindingDB Entry DOI: 10.7270/Q2WD3Z5S |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85996
([leu13]pMOT(1-9))Show SMILES CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(N)=O |r| Show InChI InChI=1S/C54H74N10O13/c1-6-31(4)45(62-51(74)41-18-13-25-64(41)54(77)44(30(2)3)61-48(71)37(55)26-33-14-9-7-10-15-33)52(75)60-40(27-34-16-11-8-12-17-34)50(73)63-46(32(5)65)53(76)59-39(28-35-19-21-36(66)22-20-35)49(72)57-29-42(67)58-38(47(56)70)23-24-43(68)69/h7-12,14-17,19-22,30-32,37-41,44-46,65-66H,6,13,18,23-29,55H2,1-5H3,(H2,56,70)(H,57,72)(H,58,67)(H,59,76)(H,60,75)(H,61,71)(H,62,74)(H,63,73)(H,68,69)/t31-,32+,37-,38-,39-,40-,41-,44-,45-,46-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 4.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86001
([leu13]pMOT(1-7))Show SMILES CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O |r| Show InChI InChI=1S/C47H64N8O9/c1-6-28(4)39(53-44(61)37-18-13-23-55(37)47(64)38(27(2)3)52-42(59)34(48)24-30-14-9-7-10-15-30)45(62)51-36(26-31-16-11-8-12-17-31)43(60)54-40(29(5)56)46(63)50-35(41(49)58)25-32-19-21-33(57)22-20-32/h7-12,14-17,19-22,27-29,34-40,56-57H,6,13,18,23-26,48H2,1-5H3,(H2,49,58)(H,50,63)(H,51,62)(H,52,59)(H,53,61)(H,54,60)/t28-,29+,34-,35-,36-,37-,38-,39-,40-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 6.92E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM85985
([leu13]pMOT(1-5))Show SMILES CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r| Show InChI InChI=1S/C34H48N6O5/c1-5-22(4)29(33(44)37-26(30(36)41)20-24-15-10-7-11-16-24)39-32(43)27-17-12-18-40(27)34(45)28(21(2)3)38-31(42)25(35)19-23-13-8-6-9-14-23/h6-11,13-16,21-22,25-29H,5,12,17-20,35H2,1-4H3,(H2,36,41)(H,37,44)(H,38,42)(H,39,43)/t22-,25-,26-,27-,28-,29-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 8.91E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
Biochem Biophys Res Commun 293: 1223-7 (2002)
Article DOI: 10.1016/S0006-291X(02)00356-X
BindingDB Entry DOI: 10.7270/Q2KP80RP |
More data for this
Ligand-Target Pair | |
Promotilin
(Homo sapiens (Human)) | BDBM86687
(ME36)Show SMILES CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(C2O)N(C)CC#C)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O Show InChI InChI=1S/C39H67NO13/c1-14-16-40(12)26-17-21(4)49-36(30(26)42)53-34-23(6)31(52-28-19-38(10,48-13)33(44)25(8)50-28)24(7)35(45)51-27(15-2)39(11,47)32(43)22(5)29(41)20(3)18-37(34,9)46/h1,20-28,30-34,36,42-44,46-47H,15-19H2,2-13H3 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Katholieke Universiteit Leuven
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 313: 1397-405 (2005)
Article DOI: 10.1124/jpet.104.081497
BindingDB Entry DOI: 10.7270/Q2WD3Z5S |
More data for this
Ligand-Target Pair | |
Search and Browse
